Rapamycin + doxorubicin
Intervention1 paper1 findingPubChem 5284616PubChem 31703ChEBI 9168ChEBI 28748
- Animals1
Outcomes
1Lung cancer
downin mice1
1 study
Lung cancer
downin mice1
Rapamycin + doxorubicin decreases lung cancer in mice.
Animalschemoresistant lung cancer modelL1CAM aptamer-modified DPPC nanoliposomeslung
Inhalable nanoliposomes target senescence and overcome chemoresistance in mouse lung cancer · Biomaterials · 23 Sep 2026
Latest
1AnimalsCellular senescence
Inhalable nanoliposomes target senescence and overcome chemoresistance in mouse lung cancer
The formulation co-delivers rapamycin and doxorubicin across the mucus barrier to inhibit mTOR and suppress tumor growth without evident systemic toxicity.